In current study, we observed that VSIR showed a unique expression pattern distinct from other immune‐checkpoint genes in gastric cancer, which indicated that not all gastric cancer might have the same immunotherapeutic responsiveness. This evidence concerns the gene VSIR and gastric cancer.